Life Science Integrates

🌟 Towards Gender Equality & The Growth of FemTech 🌟 𝗔𝗿𝗲 𝘆𝗼𝘂 𝗷𝗼𝗶𝗻𝗶𝗻𝗴 𝘂𝘀 𝗻𝗲𝘅𝘁 𝗺𝗼𝗻𝘁𝗵 𝗶𝗻 𝗠𝗮𝗻𝗰𝗵𝗲𝘀𝘁𝗲𝗿 𝗳𝗼𝗿 𝗙𝗲𝗺𝗛𝗲𝗮𝗹𝘁𝗵 𝗜𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗲𝘀 𝟮𝟬𝟮𝟱? This new event from the Life Science Integrates team is dedicated to addressing the gender gap in healthcare. And with a line up featuring some of the biggest names in the industry, it's set to be an essential platform for individuals of all genders to unite and drive change towards a more inclusive and equal future in biotech and healthcare. 💬 𝗞𝗲𝘆 𝘀𝗽𝗲𝗮𝗸𝗲𝗿𝘀 𝗶𝗻𝗰𝗹𝘂𝗱𝗲: Eleni Menegatou, Strategic Marketing Lead at Roche Yasmin Baba, Co-Founder and Chief Technology Officer at Amilis Alex Hogarty, Global Head of Wellbeing at Novartis Josiane Chuisseu PhD, Global Commercial Vice President at Cellular Highways Jordan Dargue, Co-Founder of Lifted Ventures Stasa Stankovic, Co-Founder of OvartiX Don't miss out on this powerful opportunity to learn, connect, and make an impact! 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗻𝗼𝘄: https://lnkd.in/ezkxD_Y3 📅𝟭𝟴𝘁𝗵 𝗠𝗮𝗿𝗰𝗵 𝟮𝟬𝟮𝟱 | 𝗖𝗶𝗿𝗰𝗹𝗲 𝗦𝗾𝘂𝗮𝗿𝗲, 𝗠𝗮𝗻𝗰𝗵𝗲𝘀𝘁𝗲𝗿 Explore the full agenda and full list of speakers here👉 https://lnkd.in/ezkxD_Y3 #FemHealthIntegrates #WomensHealth #FemTech #GenderEqualityInHealthcare #WomenInSTEM

𝗦𝗣𝗘𝗔𝗞𝗘𝗥 𝗦𝗣𝗢𝗧𝗟𝗜𝗚𝗛𝗧: 𝗔 𝗤&𝗔 𝗪𝗜𝗧𝗛 𝗝𝗢𝗥𝗜𝗦 𝗗𝗘 𝗞𝗘𝗜𝗝𝗦𝗘𝗥 We spoke with Joris De Keijser from Ajinomoto Bio-Pharma Services, facilitator of our upcoming Pharma Sustainability Integrates panel discussion - Zero carbon by design: Building carbon efficiency into new product design and manufacture. Joris will be joined by panellists Mark Talford from Innovate UK , Steve Swallow from AstraZeneca, Deborah McElhone from Medicines Manufacturing Innovation Centre, CPI, and Wouter Biesemans from Ajinomoto Bio-Pharma Services for a deep dive into conserving natural resources across our industry. 📅𝟮𝟱𝘁𝗵 𝗙𝗲𝗯𝗿𝘂𝗮𝗿𝘆 𝟮𝟬𝟮𝟱 | 𝗧𝗵𝗲 𝗗𝗜𝗦𝗖, 𝗖𝗮𝗺𝗯𝗿𝗶𝗱𝗴𝗲 ❓ What factors are driving the push for sustainability in pharma, and why is now the time to act? "Internal climate pledges, regulatory frameworks, and reporting are all important, as is the need for transparency throughout. We’re already seeing the effects of climate change, so now really is the time to act. Postponing action will only require more drastic measures." ❓ What do you see as the biggest challenge the sector faces in achieving meaningful sustainability goals? "Regulatory framework results in extra costs when changes are implemented and there is limited willingness to pay a premium. It also takes time to make big changes e.g. moving from a linear, petro-based to a circular based process. On top of that, the understanding of product carbon footprint is complex due to different influencing factors that can result in a perceived lack of ownership and an unwillingness to drive change. As mentioned though, the key issue is that the longer society waits to make changes, then the greater the efforts will have to be - there is a cost of doing nothing. The industry could (and should) co-drive the regulatory landscape to make changes towards sustainable productions more feasible." ❓ What are some of the most promising strategies or innovations you've seen for reducing the environmental footprint of pharmaceutical operations? "In general, there is a lack of regulatory framework that is fit for net-zero purposes so improving this could help. For example, changes to the policies could make solvent recycling easier to implement. Using solvents from circular sources, such as carbon capture and utilisation (CCU) facilities is another possibility. Realistic changes are technologies such as continuous flow manufacturing, biocatalysis, and mechanochemistry." Join us at #PharmaSustainabilityIntegrates 2025 to be part of the conversation on revolutionising the future of medicine with eco-innovative design, and paving the way to a zero-carbon footprint. 𝗟𝗮𝘀𝘁 𝗳𝗲𝘄 𝗽𝗹𝗮𝗰𝗲𝘀 𝗿𝗲𝗺𝗮𝗶𝗻𝗶𝗻𝗴! 𝗕𝗼𝗼𝗸 𝘆𝗼𝘂𝗿 𝘀𝗽𝗼𝘁 𝗻𝗼𝘄 𝘁𝗼 𝗮𝘃𝗼𝗶𝗱 𝗱𝗶𝘀𝗮𝗽𝗽𝗼𝗶𝗻𝘁𝗺𝗲𝗻𝘁: https://lnkd.in/eZyuHAFZ

𝗕𝗲𝘆𝗼𝗻𝗱 𝗣𝗿𝗼𝗺𝗶𝘀𝗲𝘀: 𝗘𝘃𝗶𝗱𝗲𝗻𝗰𝗲-𝗕𝗮𝘀𝗲𝗱 𝗦𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗶𝗻 𝗣𝗵𝗮𝗿𝗺𝗮 Sustainability in pharma needs more than good intentions—it requires robust data, measurable impact, and clear accountability. At Pharma Sustainability Integrates 2025, we’re tackling how the industry can move from pledges to evidence-based action. Here’s a taster of two of our upcoming panel discussions: 📈 𝗦𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗠𝗲𝘁𝗿𝗶𝗰𝘀: 𝗠𝗲𝗮𝘀𝘂𝗿𝗶𝗻𝗴 𝗪𝗵𝗮𝘁 𝗠𝗮𝘁𝘁𝗲𝗿𝘀 How do we ensure we’re tracking what truly drives sustainability? This panel will explore the science behind key sustainability metrics, data integrity and measuring real-world impact. Chaired by: Nazneen Rahman (YewMaker & AstraZeneca ) Panellists: Jason LaRoche (Johnson & Johnson Innovative Medicine), Niklaus Künzle (Lonza ), Marijn Verhoef (Access to Medicine Foundation), Martin Chilcott ( Manufacture 2030 | M2030) 🌱 𝗛𝗼𝘄 𝗚𝗿𝗲𝗲𝗻 𝗶𝘀 𝘆𝗼𝘂𝗿 𝗩𝗮𝗹𝗹𝗲𝘆? 𝗗𝗼 𝘄𝗲 𝗻𝗲𝗲𝗱 𝗻𝗲𝘄 𝗿𝗲𝗽𝗼𝗿𝘁𝗶𝗻𝗴 𝗹𝗮𝘄𝘀? Can new "green laws" help ensure companies back their sustainability claims with solid data? This session will unpack the fine line between genuine progress and greenwashing. Chaired by: Hugh M. ( UCL & Real Zero ) Panelists: Stuart Helmer ( CMS), Pernilla Sörme ( My Green Lab), Jason Snape (University of York ), Lisa Murch (SAS) Join us to discuss how science-backed sustainability can reshape the future of pharma! 📅 𝟮𝟱𝘁𝗵 𝗙𝗲𝗯𝗿𝘂𝗮𝗿𝘆 𝟮𝟬𝟮𝟱 | 𝗧𝗵𝗲 𝗗𝗜𝗦𝗖, 𝗖𝗮𝗺𝗯𝗿𝗶𝗱𝗴𝗲 Register here: https://lnkd.in/eZyuHAFZ #PharmaSustainabilityIntegrates #SustainablePharma

Ahead of 𝗣𝗵𝗮𝗿𝗺𝗮 𝗦𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗜𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗲𝘀 𝟮𝟬𝟮𝟱, we spoke with Adam Liddle, Head of Sustainability at RoslinCT to find out more about his thoughts on sustainability in the sector: ❓ What do you see as the biggest challenge the sector faces in achieving meaningful sustainability goals? "There are many. Political, regulatory, industry collaboration. The global landscape of sustainability is inconsistent across geographies, and businesses need this to be as simple as possible to avoid spending too much time focusing on the metrics and reporting when the focus should be on delivering treatments to patients as effectively as possible - without doing any environmental harm." ❓ How do you envision collaboration driving sustainability across the sector? "Sustainability goals can rarely be achieved by going it alone. Industry and supply chain collaboration is essential to addressing issues such as water consumption, material sourcing and waste management within the industry. Circularity within the sector can provide a range of economic benefits but it is literally impossible to achieve without multiple parties coming together to identify solutions." ❓ Looking ahead, what major innovations or shifts do you anticipate will define sustainability in our industry over the next five years? "The shift to more digital ways of working will accelerate many sustainability opportunities through intensification of manufacturing processes and reduction of manual labour-intensive methods. Also, the rapid emergence of more cell and gene therapies will transform the lives of patients across the world, but currently these treatments are few, expensive, and take a long time to bring to market. As we innovate to discover more efficient manufacturing methods for these types of treatments, we can balance environmental impact with social good." Adam will be joining the panel on future proofing at #PharmaSustainabilityIntegrates, exploring how to empower future pharma leaders for sustainability 🌍 🌱 How can sustainability training be embedded into corporate culture? 👐 What actions are driving diversity and inclusion in pharma to ensure its future? 🎓 How can apprenticeships and early-career initiatives help tackle key sustainability challenges? Chaired by: Phoebe Garfinkel – HR Director, AstraZeneca UK Panellists: Adam Liddle – RoslinCT, Elishia A. – AstraZeneca, Ria Harris – DHL Supply Chain, Beth Knight – Lloyds Banking Group Sustainability in pharma isn’t just about tackling today’s challenges—it’s about embedding long-term change into company culture, leadership and training. This session is sure to bring about a fascinating discussion with some great takeaways and support to take forward. Will we see you there? 📅𝟮𝟱𝘁𝗵 𝗙𝗲𝗯𝗿𝘂𝗮𝗿𝘆 𝟮𝟬𝟮𝟱 | 𝗧𝗵𝗲 𝗗𝗜𝗦𝗖, 𝗖𝗮𝗺𝗯𝗿𝗶𝗱𝗴𝗲 Explore the agenda: https://lnkd.in/eZyuHAFZ #PharmaSustainabilityIntegrates #SustainablePharma

This 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗗𝗮𝘆 𝗼𝗳 𝗪𝗼𝗺𝗲𝗻 𝗮𝗻𝗱 𝗚𝗶𝗿𝗹𝘀 𝗶𝗻 𝗦𝗰𝗶𝗲𝗻𝗰𝗲, we're shining a spotlight on our upcoming and newly launched FemHealth Integrates 2025 event that's set to cover key topics like inclusion and empowerment for women in the industry, as well as help break barriers in women’s health 🚺 At 𝗙𝗲𝗺𝗛𝗲𝗮𝗹𝘁𝗵 𝗜𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗲𝘀 𝟮𝟬𝟮𝟱, we’re putting women’s health issues at the forefront—bringing together leading female industry voices, innovators and policymakers to drive real change. What’s on the agenda? 🔬 Women on Trial – How can we improve representation in clinical research? ⚕️ Ladies First? – Addressing the historic underfunding of women’s health research. 💷 Women Investing in Women – How do we create a more inclusive and impactful venture capital landscape? 👩⚕️ Culture Change – How do we empower more women in leadership across healthcare? 📈 The Future of FemTech – What’s next for the booming FemTech sector? With an incredible lineup of speakers and engaging discussions, FemHealth Integrates 2025 will set out key strategies to address the gender health gap and shape the future of women’s healthcare. Don’t miss out! Panels will be facilitated by: Steph Caird ( Mills & Reeve LLP), Vicky Protano (Mills & Reeve), Jason Mellad (Start Codon), Kathryn Simpson (Kathryn Simpson Consulting Limited), Aahuti Rai (Four Points Health) 📅𝟭𝟴𝘁𝗵 𝗠𝗮𝗿𝗰𝗵 𝟮𝟬𝟮𝟱 | 𝗖𝗶𝗿𝗰𝗹𝗲 𝗦𝗾𝘂𝗮𝗿𝗲, 𝗠𝗮𝗻𝗰𝗵𝗲𝘀𝘁𝗲𝗿 Register now: https://lnkd.in/ezkxD_Y3 Sponsors and event partners: Bruntwood SciTech, Mills & Reeve, Alto Marketing, Lifted Ventures Find out more about International Day of Women and Girls in Science: https://lnkd.in/ewY_6ij #FemHealthIntegrates #FemTech #WomensHealth #WomenInSTEM #WomenAndGirlsInScience #InternationalDayOfWomenAndGirlsInScience #DiversityInSTEM

“𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗶𝗻𝘁𝗼 𝘄𝗼𝗺𝗲𝗻’𝘀 𝗵𝗲𝗮𝗹𝘁𝗵 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝘂𝗻𝗱𝗲𝗿𝗳𝘂𝗻𝗱𝗲𝗱 𝗳𝗼𝗿 𝗱𝗲𝗰𝗮𝗱𝗲𝘀. Conditions that mostly or only affect women, such as endometriosis, pelvic floor disorders and urinary tract infections, are largely understudied compared to those that predominantly affect men. This needs to change. How can we close this gender gap in healthcare?” Lucid’s Alistair Williamson and Shelby Ayris (Cound) will tackle this issue at Life Science Integrates 𝗙𝗲𝗺𝗛𝗲𝗮𝗹𝘁𝗵 𝗜𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗲𝘀 𝟮𝟬𝟮𝟱 𝗼𝗻 𝟭𝟴𝘁𝗵 𝗠𝗮𝗿𝗰𝗵 𝟮𝟬𝟮𝟱. at Bruntwood SciTech Circle Square, Manchester. Our experience in FemTech includes imagining, designing and making devices for pelvic floor health and neuro-gastroenterology. Understanding the real challenges that women face - and how to solve them. More research is welcome, but 𝗮𝗰𝘁𝗶𝗼𝗻 𝗶𝘀 𝗺𝗼𝗿𝗲 𝘂𝗿𝗴𝗲𝗻𝘁. 𝗔𝗯𝘂𝗻𝗱𝗮𝗻𝘁 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗮𝗻𝗱 𝗴𝘂𝗶𝗱𝗮𝗻𝗰𝗲 𝗽𝗿𝗼𝘃𝗲𝘀 𝗲𝗮𝗿𝗹𝗶𝗲𝗿 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 𝗮𝗻𝗱 𝗺𝗼𝗿𝗲 𝗮𝗰𝗰𝗲𝘀𝘀𝗶𝗯𝗹𝗲 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗶𝗺𝗽𝗿𝗼𝘃𝗲𝘀 𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀 𝗮𝗻𝗱 𝗿𝗲𝗱𝘂𝗰𝗲𝘀 𝗽𝗿𝗲𝘀𝘀𝘂𝗿𝗲 𝗼𝗻 𝘀𝗲𝗿𝘃𝗶𝗰𝗲𝘀. In FemHealth, treatment delays aren’t just statistics - they have a profound impact on women’s lives. 𝗧𝗵𝗲 𝗯𝗶𝗴𝗴𝗲𝘀𝘁 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲 𝗶𝘀𝗻’𝘁 𝗷𝘂𝘀𝘁 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗼𝗿 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 - 𝗶𝘁’𝘀 𝗮𝗱𝗼𝗽𝘁𝗶𝗼𝗻. We’re pushing for real change, ensuring the right pathways, funding and infrastructure are in place to get better solutions into healthcare systems - fast. How would you close the gender gap in healthcare? We’d love to hear your thoughts in the comments below 👇 View event details here: https://lnkd.in/ezkxD_Y3 #FemHealth #FemTech #lifescience #healthcare

𝙄𝙨 𝙘𝙧𝙤𝙨𝙨-𝙞𝙣𝙙𝙪𝙨𝙩𝙧𝙮 𝙘𝙤𝙡𝙡𝙖𝙗𝙤𝙧𝙖𝙩𝙞𝙤𝙣 𝙩𝙝𝙚 𝙠𝙚𝙮 𝙩𝙤 𝙖 𝙩𝙧𝙪𝙡𝙮 𝙨𝙪𝙨𝙩𝙖𝙞𝙣𝙖𝙗𝙡𝙚 𝙥𝙝𝙖𝙧𝙢𝙖𝙘𝙚𝙪𝙩𝙞𝙘𝙖𝙡 𝙞𝙣𝙙𝙪𝙨𝙩𝙧𝙮? At Pharma Sustainability Integrates 2025, our fireside chat entitled "Scaling Innovation: Collaborative Solutions for NHS and Global Health Systems" will bring together top industry leaders to explore how cross-sector partnerships can drive meaningful change. Let's explore: •        How can the UK become a world leader in sustainable global supply chains? •        What role does supplier diversity play in ensuring future sustainability? •        How can we bridge the gap between pharma and healthtech to drive long-term progress? Facilitated by: Dave Tudor – Managing Director, CPI, Medicines Manufacturing Innovation Centre Speakers: Rachel Castle – Director, Global Sustainability Policy & Advocacy, GSK; Philipp Lukas – CEO, Future Biogas; Robert Williams – Senior Director, Sustainable Procurement, AstraZeneca & Chair, PSCI - Pharmaceutical Supply Chain Initiative; Cassandra Brown – Commercial Director, Manufacture 2030 | M2030 Don’t miss this opportunity to hear from leading voices in pharma sustainability and gain valuable industry insights. 📅𝟮𝟱𝘁𝗵 𝗙𝗲𝗯𝗿𝘂𝗮𝗿𝘆 𝟮𝟬𝟮𝟱 | 𝗧𝗵𝗲 𝗗𝗜𝗦𝗖, 𝗖𝗮𝗺𝗯𝗿𝗶𝗱𝗴𝗲 Register now: https://lnkd.in/eZyuHAFZ #PharmaSustainabilityIntegrates #SustainablePharma

We're looking forward to seeing Duncan Flack and Maryam A. Babba, Ph.D. from CiPPPA at Pharma Sustainability Integrates in a few weeks - Duncan will be chairing the panel on "Circularity in healthcare, are we going round in circles?" which looks set to be a great discussion on how to effectively operationalise waste management and circularity in healthcare. You can see the full agenda for the day here - https://lnkd.in/eZyuHAFZ

🌱🏥 Rethinking Patient Pathways for a Low-Carbon Future As sustainability in pharma becomes ever more critical, decarbonising patient pathways is essential to reducing the industry’s environmental impact. But where do we start? At Pharma Sustainability Integrates 2025, we’ll explore how systems thinking can help reshape care pathways to be both effective and environmentally responsible. Our Panel Discussion “Decarbonising Patient Pathways” will explore: 👣 How can we use data to evaluate the carbon footprint of different care models? 🏥 What role do care pathways play in reducing healthcare’s environmental impact? 🤝 How can collaboration across diverse stakeholders accelerate change? Chaired by: Fiona Adshead – Chair, Sustainable Healthcare Coalition Panellists: Eleanor Murray – The Queen Elizabeth University Hospital, Glasgow & Centre for Sustainable Delivery (Scotland), Dr Sheuli Porkess – Faculty of Pharmaceutical Medicine & Reinventing Health, Callum White – PwC , Ekaterina Maslova – AstraZeneca Join the discussion and help shape a more sustainable healthcare system! 📅𝟮𝟱𝘁𝗵 𝗙𝗲𝗯𝗿𝘂𝗮𝗿𝘆 𝟮𝟬𝟮𝟱 | 𝗧𝗵𝗲 𝗗𝗜𝗦𝗖, 𝗖𝗮𝗺𝗯𝗿𝗶𝗱𝗴𝗲 Register now: https://lnkd.in/eZyuHAFZ #PharmaSustainabilityIntegrates #SustainablePharma

𝗖𝗹𝗼𝘀𝗶𝗻𝗴 𝘁𝗵𝗲 𝗚𝗲𝗻𝗱𝗲𝗿 𝗚𝗮𝗽 𝗶𝗻 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 🚺 Did you know that women spend 25% more of their lives in poor health than men?* Yet, for decades, women’s health concerns have been under-funded, under-researched, and under-served. From under-representation in clinical development to gaps in investment for female-specific health conditions, the industry has long overlooked the unique healthcare needs of half the population and 𝗶𝘁’𝘀 𝘁𝗶𝗺𝗲 𝗳𝗼𝗿 𝗰𝗵𝗮𝗻𝗴𝗲. That’s why we’re launching 𝗙𝗲𝗺𝗛𝗲𝗮𝗹𝘁𝗵 𝗜𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗲𝘀 𝟮𝟬𝟮𝟱—a brand-new event dedicated to driving progress and innovation in women’s health. Taking place on 𝟭𝟴𝘁𝗵 𝗠𝗮𝗿𝗰𝗵 𝟮𝟬𝟮𝟱 𝗮𝘁 𝗖𝗶𝗿𝗰𝗹𝗲 𝗦𝗾𝘂𝗮𝗿𝗲, 𝗠𝗮𝗻𝗰𝗵𝗲𝘀𝘁𝗲𝗿, this event will bring together powerful female leaders and innovators to address key challenges and opportunities, including: 🔬 How can we close the research gap in women’s health? 💷 Where should investment be directed to better address women’s needs? 👂 How do we reset how the healthcare system listens to women? Let’s move the conversation forward. Find out more and register here👉 https://lnkd.in/ezkxD_Y3 * https://lnkd.in/e-QUKCmK #FemHealthIntegrates #WomensHealth #FemTech #GenderEqualityInHealthcare #WomenInSTEM